{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:33:48Z","timestamp":1792787628234,"version":"4.5.0"},"reference-count":51,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R21NS114615"],"award-info":[{"award-number":["1R21NS114615"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"DOD Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["CA-170319"],"award-info":[{"award-number":["CA-170319"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Debbie\u2019s Brain Cancer Research Fund","award":["13100"],"award-info":[{"award-number":["13100"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Glioblastoma (GBM) tumors remain a challenge for immunotherapy owing to their heterogeneous and immunologically cold properties. GBM cells change the composition of the neural extracellular matrix (ECM), affecting the mobility, survival, and function of immune cells such as tumor-associated microglia and infiltrated macrophages (TAM). The ECM protein fibulin-3\/EFEMP1 is a pericellular component uniquely upregulated in GBM compared with the normal brain, which promotes tumor growth and invasion. In this study, we demonstrate that fibulin-3 indirectly modulates TAM behavior and can be targeted to restore innate immune responses. Intracranial tumors initiated by fibulin-3\u2013deficient GBM cells showed increased presence of TAMs with decreased immunosuppression markers (arginase-1, CD206), whereas the opposite effects were observed in tumors overexpressing fibulin-3. In silico analyses revealed a positive correlation between fibulin-3 and an immunosuppressive signature that was validated in GBM stem cells and in vivo. We further demonstrated that fibulin-3 regulates the expression of immunosuppressive signals (CSF-1, TGF-\u03b21, and CD47) by autocrine activation of NF-\u03baB signaling. Immunosuppressive signals were downregulated by knockdown of fibulin-3 in GBM stem cells and by inhibition of this protein using an anti\u2013fibulin-3 antibody. Myeloid cells exhibited higher phagocytic activity and killing of GBM cells in presence of this antibody. Furthermore, locoregional delivery of anti\u2013fibulin-3 in mice with intracranial GBM increased the presence of proinflammatory TAMs, thereby reducing tumor viability. Our findings show that anti\u2013fibulin-3 approaches, which affect the ECM surrounding tumor and immune cells, can diminish immunosuppression in GBM and boost innate immune responses against the tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Inhibition of the ECM protein fibulin-3, which is highly upregulated in glioblastoma tumors, decreases immunosuppressive signals produced by the tumor cells and exposes them to increased attack by TAMs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0083","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:36:54Z","timestamp":1755862614000},"page":"1599-1610","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of Extracellular Matrix Protein Fibulin-3 Reduces Immunosuppressive Signaling and Increases Macrophage Activation in Glioblastoma"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0412-5065","authenticated-orcid":false,"given":"Somanath","family":"Kundu","sequence":"first","affiliation":[{"name":"1Department of Neuroscience and Physiology, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4693-0006","authenticated-orcid":false,"given":"Soham","family":"Mitra","sequence":"additional","affiliation":[{"name":"1Department of Neuroscience and Physiology, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9842-3508","authenticated-orcid":false,"given":"Arivazhagan","family":"Roshini","sequence":"additional","affiliation":[{"name":"1Department of Neuroscience and Physiology, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4827-0068","authenticated-orcid":false,"given":"John A.","family":"Longo","sequence":"additional","affiliation":[{"name":"1Department of Neuroscience and Physiology, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1967-9730","authenticated-orcid":false,"given":"Sharon L.","family":"Longo","sequence":"additional","affiliation":[{"name":"2Department of Neurosurgery, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7495-7386","authenticated-orcid":false,"given":"Abigail G.","family":"Venskus","sequence":"additional","affiliation":[{"name":"2Department of Neurosurgery, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8985-7526","authenticated-orcid":false,"given":"Harish","family":"Babu","sequence":"additional","affiliation":[{"name":"2Department of Neurosurgery, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8756-388X","authenticated-orcid":false,"given":"Mariano S.","family":"Viapiano","sequence":"additional","affiliation":[{"name":"1Department of Neuroscience and Physiology, State University of New York - Upstate Medical University, Syracuse, New York."},{"name":"2Department of Neurosurgery, State University of New York - Upstate Medical University, Syracuse, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"12 Suppl 2","key":"2025091103490919300_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"2025091103490919300_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","article-title":"Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective","volume":"187","author":"Mathur","year":"2024","journal-title":"Cell"},{"key":"2025091103490919300_bib3","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.3390\/cancers16193273","article-title":"Barriers to T cell functionality in the glioblastoma microenvironment","volume":"16","author":"Nader","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025091103490919300_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2022.04.010","article-title":"Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma","volume":"8","author":"Pang","year":"2022","journal-title":"Trends Cancer"},{"key":"2025091103490919300_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuron.2019.08.028","article-title":"Microglia\/brain macrophages as central drivers of brain tumor pathobiology","volume":"104","author":"Gutmann","year":"2019","journal-title":"Neuron"},{"key":"2025091103490919300_bib6","doi-asserted-by":"crossref","first-page":"e163446","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J Clin Invest"},{"key":"2025091103490919300_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2025091103490919300_bib8","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1038\/s41467-018-05346-7","article-title":"Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis","volume":"9","author":"Muliaditan","year":"2018","journal-title":"Nat Commun"},{"key":"2025091103490919300_bib9","doi-asserted-by":"crossref","first-page":"110583","DOI":"10.1016\/j.intimp.2023.110583","article-title":"Biochemical and molecular inducers and modulators of M2 macrophage polarization in clinical perspective","volume":"122","author":"Kiseleva","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2025091103490919300_bib10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41467-021-21407-w","article-title":"Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages","volume":"12","author":"Ochocka","year":"2021","journal-title":"Nat Commun"},{"issue":"Suppl 7","key":"2025091103490919300_bib11","doi-asserted-by":"crossref","first-page":"vii32","DOI":"10.1093\/neuonc\/nov178","article-title":"Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy","volume":"17","author":"Reardon","year":"2015","journal-title":"Neuro Oncol"},{"key":"2025091103490919300_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.celrep.2017.10.030","article-title":"Single-cell RNA-seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma","volume":"21","author":"Darmanis","year":"2017","journal-title":"Cell Rep"},{"key":"2025091103490919300_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1126\/science.aaf2666","article-title":"An anatomic transcriptional atlas of human glioblastoma","volume":"360","author":"Puchalski","year":"2018","journal-title":"Science"},{"key":"2025091103490919300_bib14","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.1016\/j.mcpro.2022.100216","article-title":"In-depth matrisome and glycoproteomic analysis of human brain glioblastoma versus control tissue","volume":"21","author":"Sethi","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"2025091103490919300_bib15","doi-asserted-by":"crossref","first-page":"020902","DOI":"10.1063\/5.0043338","article-title":"Progress in mimicking brain microenvironments to understand and treat neurological disorders","volume":"5","author":"Ngo","year":"2021","journal-title":"APL Bioeng"},{"key":"2025091103490919300_bib16","doi-asserted-by":"crossref","first-page":"1336476","DOI":"10.3389\/fimmu.2024.1336476","article-title":"Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy","volume":"15","author":"Collado","year":"2024","journal-title":"Front Immunol"},{"key":"2025091103490919300_bib17","doi-asserted-by":"crossref","first-page":"1005069","DOI":"10.3389\/fonc.2022.1005069","article-title":"The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications","volume":"12","author":"Faisal","year":"2022","journal-title":"Front Oncol"},{"key":"2025091103490919300_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-59038-3_1","article-title":"Targeting glioblastoma tumor microenvironment","volume":"1296","author":"Butler","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"2025091103490919300_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-030-48457-6_9","article-title":"Tenascin-C function in glioma: immunomodulation and beyond","volume":"1272","author":"Yalcin","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"2025091103490919300_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/1078-0432.CCR-20-2400","article-title":"Modification of extracellular matrix enhances oncolytic adenovirus immunotherapy in glioblastoma","volume":"27","author":"Kiyokawa","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025091103490919300_bib21","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1002\/1878-0261.13315","article-title":"Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas","volume":"16","author":"Zhang","year":"2022","journal-title":"Mol Oncol"},{"key":"2025091103490919300_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI121266","article-title":"Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target","volume":"129","author":"Wei","year":"2019","journal-title":"J Clin Invest"},{"key":"2025091103490919300_bib23","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1158\/1541-7786.MCR-09-0207","article-title":"Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion","volume":"7","author":"Hu","year":"2009","journal-title":"Mol Cancer Res"},{"key":"2025091103490919300_bib24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/biom10091294","article-title":"The pathophysiological significance of fibulin-3","volume":"10","author":"Livingstone","year":"2020","journal-title":"Biomolecules"},{"key":"2025091103490919300_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/biom11050685","article-title":"Role of fibulins in embryonic stage development and their involvement in various diseases","volume":"11","author":"Mahajan","year":"2021","journal-title":"Biomolecules"},{"key":"2025091103490919300_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1078-0432.CCR-17-1628","article-title":"Development of a function-blocking antibody against fibulin-3 as a targeted reagent for glioblastoma","volume":"24","author":"Nandhu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025091103490919300_bib27","doi-asserted-by":"crossref","first-page":"1014749","DOI":"10.3389\/fonc.2022.1014749","article-title":"The extracellular matrix protein fibulin-3\/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K\/Akt signaling","volume":"12","author":"Roshini","year":"2022","journal-title":"Front Oncol"},{"key":"2025091103490919300_bib28","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1158\/0008-5472.CAN-12-1060","article-title":"Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res"},{"key":"2025091103490919300_bib29","article-title":"Prometheus(tm): a novel approach for engineering manufacturable humanized antibodies","author":"Wilkinson","year":"2019"},{"key":"2025091103490919300_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro Oncol"},{"key":"2025091103490919300_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"2025091103490919300_bib32","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1038\/onc.2017.109","article-title":"Tumor-derived fibulin-3 activates pro-invasive NF-\u03baB signaling in glioblastoma cells and their microenvironment","volume":"36","author":"Nandhu","year":"2017","journal-title":"Oncogene"},{"key":"2025091103490919300_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.18632\/oncotarget.1620","article-title":"EFEMP1 induces \u03b3-secretase\/Notch-mediated temozolomide resistance in glioblastoma","volume":"5","author":"Hiddingh","year":"2014","journal-title":"Oncotarget"},{"key":"2025091103490919300_bib34","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-14-0685","article-title":"Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas","volume":"74","author":"Nandhu","year":"2014","journal-title":"Cancer Res"},{"issue":"Suppl 4","key":"2025091103490919300_bib35","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.33549\/physiolres.933526","article-title":"Athymic nude mice as an experimental model for cancer treatment","volume":"65","author":"Szadvari","year":"2016","journal-title":"Physiol Res"},{"key":"2025091103490919300_bib36","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3390\/cancers15061879","article-title":"The extracellular matrix in glioblastomas: a glance at its structural modifications in shaping the tumoral microenvironment-A systematic review","volume":"15","author":"Marino","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025091103490919300_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","article-title":"Transcriptome analysis reveals tumor microenvironment changes in glioblastoma","volume":"41","author":"Hoogstrate","year":"2023","journal-title":"Cancer Cell"},{"key":"2025091103490919300_bib38","doi-asserted-by":"crossref","first-page":"2000244","DOI":"10.1002\/adtp.202000244","article-title":"Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican","volume":"4","author":"von Spreckelsen","year":"2021","journal-title":"Adv Ther (Weinh)"},{"key":"2025091103490919300_bib39","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1002\/jgm.2942","article-title":"Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide","volume":"19","author":"Jaime-Ramirez","year":"2017","journal-title":"J Gene Med"},{"key":"2025091103490919300_bib40","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1078-0432.CCR-10-2213","article-title":"Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy","volume":"17","author":"Dmitrieva","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2025091103490919300_bib41","doi-asserted-by":"crossref","first-page":"108577","DOI":"10.1016\/j.pharmthera.2023.108577","article-title":"Clinical advances in TNC delivery vectors and their conjugate agents","volume":"253","author":"Chen","year":"2024","journal-title":"Pharmacol Ther"},{"key":"2025091103490919300_bib42","doi-asserted-by":"crossref","first-page":"eabb2311","DOI":"10.1126\/scitranslmed.abb2311","article-title":"Immunocytokines are a promising immunotherapeutic approach against glioblastoma","volume":"12","author":"Weiss","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025091103490919300_bib43","doi-asserted-by":"crossref","first-page":"eaaw7843","DOI":"10.1126\/scitranslmed.aaw7843","article-title":"Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance","volume":"12","author":"Akkari","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025091103490919300_bib44","doi-asserted-by":"crossref","first-page":"aad3018","DOI":"10.1126\/science.aad3018","article-title":"The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas","volume":"352","author":"Quail","year":"2016","journal-title":"Science"},{"key":"2025091103490919300_bib45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 immune checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"2025091103490919300_bib46","doi-asserted-by":"crossref","first-page":"20587392211000899","DOI":"10.1177\/20587392211000899","article-title":"CD47 is highly expressed in gliomas and targeting CD47 is a promising therapeutic strategy","volume":"19","author":"Yang","year":"2021","journal-title":"Eur J Inflamm"},{"key":"2025091103490919300_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.32604\/or.2023.042383","article-title":"Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy","volume":"32","author":"Chen","year":"2023","journal-title":"Oncol Res"},{"key":"2025091103490919300_bib48","doi-asserted-by":"crossref","first-page":"e0201832","DOI":"10.1371\/journal.pone.0201832","article-title":"ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile","volume":"13","author":"Kauder","year":"2018","journal-title":"PLoS One"},{"key":"2025091103490919300_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jprot.2014.01.024","article-title":"Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression","volume":"99","author":"Tarassishin","year":"2014","journal-title":"J Proteomics"},{"key":"2025091103490919300_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10571-024-01488-z","article-title":"Extracellular matrix structure and interaction with immune cells in adult astrocytic tumors","volume":"44","author":"Di Vito","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"2025091103490919300_bib51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/bioengineering11010093","article-title":"Biophysical control of the glioblastoma immunosuppressive microenvironment: opportunities for immunotherapy","volume":"11","author":"Teer","year":"2024","journal-title":"Bioengineering (Basel)"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0083\/3644210\/crc-25-0083.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/9\/1599\/3650484\/crc-25-0083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/9\/1599\/3650484\/crc-25-0083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:49:25Z","timestamp":1757576965000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/9\/1599\/765099\/Inhibition-of-Extracellular-Matrix-Protein-Fibulin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0083","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30102507","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102528","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102525","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102558","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102513","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102546","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102516","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102549","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102504","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102510","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102531","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102501","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102534","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102522","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102555","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102552","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30102540","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8028840","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}